Regulus Therapeutics
RGLS
#9072
Rank
ยฃ74.96 M
Marketcap
ยฃ1.14
Share price
7.25%
Change (1 day)
-39.70%
Change (1 year)

Earnings for Regulus Therapeutics (RGLS)

Earnings in 2024 (TTM): -ยฃ32.07 Million

According to Regulus Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -ยฃ22.77 Million a decrease over its 2022 earnings that were of -ยฃ21.37 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regulus Therapeutics from 2012 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -ยฃ32.07 Million40.86%
2023 -ยฃ22.77 Million6.51%
2022 -ยฃ21.37 Million2.53%
2021 -ยฃ20.85 Million93.59%
2020 -ยฃ10.77 Million-15.41%
2019 -ยฃ12.73 Million-64.46%
2018 -ยฃ35.81 Million-33.26%
2017 -ยฃ53.66 Million-13.98%
2016 -ยฃ62.38 Million44.77%
2015 -ยฃ43.09 Million-1.63%
2014 -ยฃ43.81 Million203.6%
2013 -ยฃ14.43 Million8.65%
2012 -ยฃ13.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ3.22 B-10,182.11%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ6.14 B-19,298.05%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ1.47 B-4,707.31%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.06 B-25,319.37%๐Ÿ‡ฌ๐Ÿ‡ง UK
-ยฃ0.19 Billion 469.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.11 Billion 224.45%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ6.48 Billion 20,154.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ90.99 Million 184.40%๐Ÿ‡บ๐Ÿ‡ธ USA